UBS AG has set preliminary terms for trigger autocallable contingent Yield notes linked to the Solactive U.S. Large Cap Volatility Navigator Index, with a $1,000.00 public issue price per note. Investors would take exposure to UBS AG’s unsecured obligations and an index-linked structure whose value can be affected by market and Credit factors.
Key Highlights
- UBS Securities LLC will receive a $2.50 Underwriting discount for each note sold.
- UBS Securities LLC may pay an unaffiliated dealer a $20.00 Marketing fee per note.
- UBS Securities LLC’s affiliation with UBS AG creates a conflict of interest under FINRA Rule 5121.
UBS AG will sell all of the notes to its affiliate UBS Securities LLC at the public issue price less the underwriting discount, while UBS Securities LLC intends to resell them to third-party dealers at a reduction equal to that discount. UBS Securities LLC will receive $2.50 per note as underwriting compensation, leaving proceeds to UBS AG of $997.50 per note sold.
Investor Insights
The notes’ value can be influenced by the index and its constituents, volatility, interest rates, geopolitical and economic conditions, regulatory or judicial events, UBS AG’s creditworthiness and the prevailing bid-ask spread.
FAQs
Q: What are UBS AG’s autocallable notes linked to?
A: Their preliminary public issue price is $1,000 per note. UBS AG will sell all of the notes to UBS Securities LLC at the public issue price less the underwriting discount.
Q: What is the maturity date for UBS AG’s notes?
A: The notes are due on or about September 15, 2031. UBS AG will sell all of the notes to its affiliate UBS Securities LLC, which intends to resell them to third-party dealers.
Q: What fees apply to the UBS AG notes offering?
A: UBS Securities LLC will receive a $2.50 underwriting discount per note. It may also pay an unaffiliated dealer a $20.00 marketing fee for some or all of the notes.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.